Lexeo Therapeutics Inc.’s recently made public that its Chief Executive Officer Townsend Richard Nolan unloaded Company’s shares for reported $40496.0 on Oct 10 ’24. In the deal valued at $8.10 per share,5,000 shares were sold. As a result of this transaction, Townsend Richard Nolan now holds 120,695 shares worth roughly $1.34 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Townsend Richard Nolan sold 5,000 shares, generating $53,274 in total proceeds. Upon selling the shares at $10.65, the Chief Executive Officer now owns 120,695 shares.
Before that, Richard Nolan Townsend bought 12,500 shares. Lexeo Therapeutics Inc. shares valued at $134,875 were divested by the Director at a price of $10.79 per share.
Robert W. Baird initiated its Lexeo Therapeutics Inc. [LXEO] rating to an Outperform in a research note published on June 13, 2024; the price target was $28. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early June with a ‘”a Buy”‘ rating. Stifel began covering LXEO with “Buy” recommendation on November 28, 2023. RBC Capital Mkts started covering the stock on November 28, 2023. It rated LXEO as “an Outperform”.
Price Performance Review of LXEO
On Friday, Lexeo Therapeutics Inc. [NASDAQ:LXEO] saw its stock jump 22.20% to $11.12. Over the last five days, the stock has gained 35.78%. Lexeo Therapeutics Inc. shares have fallen nearly -17.14% since the year began. SMA at 50 days reached $10.25, while 200 days put it at $13.63.
Levels Of Support And Resistance For LXEO Stock
The 24-hour chart illustrates a support level at 9.75, which if violated will result in even more drops to 8.37. On the upside, there is a resistance level at 11.83. A further resistance level may holdings at 12.54. The Relative Strength Index (RSI) on the 14-day chart is 64.96, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.98, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 1.51%. Stochastics %K at 89.05% indicates the stock is a selling.
How much short interest is there in Lexeo Therapeutics Inc.?
A steep rise in short interest was recorded in Lexeo Therapeutics Inc. stocks on 2024-09-30, growing by 0.83 million shares to a total of 2.07 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 1.24 million shares. There was a rise of 40.01%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 28, 2023 when Leerink Partners began covering the stock and recommended ‘”an Outperform”‘ rating along with a $19 price target.
